AU Patent

AU2019200424A1 — Pharmaceutical composition of S-ketamine hydrochloride

Assigned to Janssen Pharmaceutica NV · Expires 2019-02-14 · 7y expired

What this patent protects

OF THE INVENTION The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.

USPTO Abstract

OF THE INVENTION The present invention is directed to an aqueous formulation of S-ketamine hydrochloride, preferably for nasal administration, wherein the formulation does not contain an antimicrobial preservative.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019200424A1
Jurisdiction
AU
Classification
—
Expires
2019-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.